Login

Renren received a non-binding preliminary 'going private' offer from top executives at $4.20 per share in cash for each American depositary share. 00:10:00

Share On Facebook Share On Twitter

Joseph Chen and Chen Ji are the CEOs of Renren

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Expansion and Success in New Core Gold's Drill Program
00:10:00
Introduction to Dynamic Mining: An Emerging Guinea Bauxite Project
00:10:00
Ulrika Jonsson Discusses Quarterly Report and Cost Optimization Strategies at Brilliant Future | Ulrika Jonsson, CEO, Brilliant Future AB.
00:10:00
Daniel Pipes on the Core of Islam and its Historical Aggressiveness|Daniel Pipes
00:10:00
Timmins Mechanical Solutions Unveils New 12,000 Sq. Ft. Facility with Enhanced Features
00:10:00
From Entrepreneurial Dreams to Corporate Leadership: Al's Journey at PLDT Smart | Al Panlilio, CEO, PLDT Inc.
00:10:00
Q&A with Neal Barclay, CEO of Meridian Energy, on European politics' impact discussed in Craigs Investment Partners' Weekly Update.
00:10:00
Templeton Global Balanced Fund: A Strategic Approach to Diversified Investing | Jane Doe, Portfolio Manager, Templeton Global Balanced Fund, Franklin Templeton Investments
00:10:00
Fostering a Collaborative Culture at KKR
00:10:00
Cosan s.a.c. Comercial y Servicios de Accesorios Nacionales | Nelson Roseira Gomes Neto, CEO, Cosan SACSAN3:SAO
00:10:00
The Best VC Pitches Gets Right to the Point|Nick Adams,Co-Founder, Managing Partner,Differential Ventures
00:10:00
Copper Market Outlook and Role in Energy Transition

© 2026 Nehu